| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.500 | None | 0.963 | 0 | 0 | 1994 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 2006 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.949 | 0 | 0 | 1995 | 2016 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.430 | None | 1.000 | 0 | 0 | 2001 | 2017 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.440 | None | 1.000 | 0 | 0 | 2000 | 2016 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2018 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.500 | None | 0.979 | 0 | 0 | 2003 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.350 | None | 1.000 | 0 | 0 | 2002 | 2012 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2009 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.420 | None | 1.000 | 0 | 0 | 2013 | 2017 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.500 | None | 0.967 | 0 | 0 | 2001 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 2009 | 2014 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1999 | 2016 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2010 | 2010 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.440 | None | 1.000 | 0 | 0 | 2005 | 2016 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
disease | 0.360 | None | 0.833 | 0 | 0 | 2004 | 2015 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
disease | 0.440 | None | 1.000 | 0 | 0 | 2014 | 2019 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2012 | 2017 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2016 | 2016 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2013 | 2013 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.800 | strong | 0.955 | 0 | 0 | 2012 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ERCC excision repair 4, endonuclease catalytic subunit | 0.468 | 0.846 | 1.4E-12 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2013 | 2016 |